Abstract
Background: Pulmonary Tuberculosis is an infectious disease caused by the bacteria Mycobacterium Tuberculosis. To reduce the number of pulmonary tuberculosis cases, treatment is carried out using OAT or what is commonly called anti-tuberculosis drugs. The length of treatment can affect the hematological system, including eosinophil cells and lymphocyte cells. An increase or decrease in the ratio of these two cells can describe the healing process of Pulmonary Tuberculosis disease.
 Method: This study was conducted to determine the description of the eosinophil lymphocyte ratio (ELR) in pulmonary tuberculosis patients based on the duration of treatment. The research method was descriptive with a cross sectional approach. The research was conducted in February-June 2023 with a total sample of 40 respondents with Pulmonary Tuberculosis in several Puskesmas in Jambi City. The research was conducted in the hematology laboratory of the Technology Laboratory Medicine, Poltekkes Kemenkes Jambi.
 Result: From the research conducted, it was found that the average ELR in patients with pulmonary tuberculosis undergoing treatment for <2 months was 0.08; the average ELR at the treatment stage >2 months was 0.12;
 Conclusion: the conclusion of the ELR independent T test based on the length of treatment with a sig value of 0.230 (p>0, 05).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
